Moneycontrol PRO
LAMF
LAMF

At Moneycontrol, the Results page helps you effectively track corporate announcements and results for various listed companies across both India and abroad. With our Results page, you can keep abreast with an updated, comprehensive view of all the profit/loss statements, company spendings, AGM outcomes, and quarterly and annual results from all these listed companies. Additionally, Moneycontrol also regularly tracks international MNCs listed on NASDAQ and Asian bourses, including popular companies like Apple, Google, Alibaba. Apart from finding solid copies of company results, stock movements consequent to these company results, expectations, and analytical post results copies, you will also find copies and articles detailing the earnings, impact, and all major announcements made to media/exchanges by these companies, so that you do not miss anything. We also provide you with concrete data points to help you spot profitable trades, stock build-ups, and bulk deals. At Moneycontrol, we also cover analysts/investors meetings; scrutinise results and data and BSE/NSE reports or news. The copies are not just full of information and data, but are also adequately supplemented with expert views, investor opinions, extensive interviews, videos, and a huge variety of explainers, analyses, and informative slideshows to help you gauge the market and make investment decisions in the best possible manner. More

Jump to
  • Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang

    Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.

  • Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang

  • Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct

  • Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher

  • Torrent Pharma Q1 PAT seen up 34.2% YoY to Rs 430.8 cr: KRChoksey

  • Torrent Pharma Q1 PAT seen up 10.8% YoY to Rs 355.7 cr: ICICI Direct

  • Torrent Pharma Q4 PAT may dip 1.9% YoY to Rs. 308 cr: Sharekhan

  • Torrent Pharma Q2 PAT seen up 8% YoY to Rs. 220.3 cr: Emkay

  • Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show

  • Torrent Pharmaceuticals Q4 PAT may dip 12.6% YoY to Rs. 199.3 cr: Kotak

  • Torrent Pharma Q3 PAT may dip 18.1% YoY to Rs. 199 cr: Sharekhan

  • Torrent Pharma Q3 PAT seen up 183.6% YoY to Rs. 164.5 cr: ICICI Direct

  • Credit Suisse expects strong Q3 quarter for Aurobindo, Torrent Pharma, Cadila

  • Torrent Pharma Q2 PAT may dip 5.4% YoY to Rs. 190 cr: HDFC Securities

  • Torrent Pharma Q2 PAT may dip 18.4% YoY to Rs. 166.5 cr: Sharekhan

  • Torrent Pharma Q2 PAT may dip 13.2% YoY to Rs. 177 cr: ICICI Direct

  • Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz

  • Torrent Pharmaceuticals Q1 PAT may dip 8.4% YoY to Rs. 172.2 cr: Kotak

  • Torrent Pharma Q4 PAT seen up 1.3% YoY to Rs. 210 cr: HDFC Securities

  • Torrent Pharmaceuticals Q4 PAT may dip 37.3% YoY to Rs. 129.3 cr: Edelweiss

  • Torrent Pharmaceuticals Q2 PAT seen up 13.9% YoY to Rs. 235.7 cr: Kotak

  • Torrent Pharma Q4 PAT may dip 8.3% to Rs 209.9 cr: ICICI Securities

  • Torrent Pharma Q3 PAT seen up 7.1% to Rs 220 cr: HDFC Securities

  • Torrent Pharma Q3 PAT seen up 15% to Rs 238 cr: ICICI Securities

  • Torrent Pharma Q2 profit seen down 52% on low operational income

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347